Myung-Sam Cho

USPTO Granted Patents = 10 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 68(Granted Patents)

Company Filing History:

Lot 41 Acquisition Foundation, LLC

patents

Years Active: 1998-2017

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9650431 - Method for treating bleeding disorders (2017-05-16),

2. 9249209 - Compositions containing factor VIII glycoforms (2016-02-02),

3. 8945869 - Factor VIII glycoforms (2015-02-03),

4. 8207117 - Methods of reducing hemorrhage due to surgical procedure (2012-06-26),

5. 7723102 - Enhanced transfection system (2010-05-25),

6. 7459525 - Factor VIII glycoforms (2008-12-02),

7. 6358703 - Expression system for factor VIII (2002-03-19),

8. 6180108 - Vectors having terminal repeat sequence of Epstein-Barr virus (2001-01-30),

9. 6136599 - Human hybrid host cell for mammalian gene expression (2000-10-24),

10. 5854021 - Enhance protein production method (1998-12-29),

Title: Myung-Sam Cho: Innovator in Glycosylated Proteins

Introduction

Myung-Sam Cho is a notable inventor based in Pinole, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of glycosylated proteins with human factor VIII activity. With a total of 10 patents to his name, Cho's work has the potential to impact treatments for bleeding disorders.

Latest Patents

Among his latest patents, Cho has developed a method for treating bleeding disorders. This invention focuses on glycosylated proteins that exhibit human factor VIII activity. In a preferred embodiment, the protein is glycosylated with oligosaccharides that include an alpha-(2,6)-linked sialic acid and a bisecting GlcNAc linked to a core beta-mannose. Additionally, he has patented compositions containing factor VIII glycoforms, which also involve similar glycosylation techniques.

Career Highlights

Throughout his career, Myung-Sam Cho has worked with prominent companies such as Bayer Corporation and Bayer Healthcare LLC. His experience in these organizations has allowed him to refine his expertise in the field of biotechnology and contribute to innovative solutions for medical challenges.

Collaborations

Some of his notable coworkers include Sham-Yuen Chan and Helena Yee. Their collaborative efforts have likely enhanced the research and development of the technologies that Cho has pioneered.

Conclusion

Myung-Sam Cho's contributions to the field of glycosylated proteins and his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments for bleeding disorders, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.